Literature DB >> 22823950

Issues to be considered when studying cancer in vitro.

Beata Cunderlíková1.   

Abstract

Various cancer treatment approaches have shown promising results when tested preclinically. The results of clinical trials, however, are often disappointing. While searching for the reasons responsible for their failures, the relevance of experimental and preclinical models has to be taken into account. Possible factors that should be considered, including cell modifications during in vitro cultivation, lack of both the relevant interactions and the structural context in vitro have been summarized in the present review.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22823950     DOI: 10.1016/j.critrevonc.2012.06.007

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  4 in total

1.  Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens.

Authors:  Xuefeng Liu; Ewa Krawczyk; Frank A Suprynowicz; Nancy Palechor-Ceron; Hang Yuan; Aleksandra Dakic; Vera Simic; Yun-Ling Zheng; Praathibha Sripadhan; Chen Chen; Jie Lu; Tung-Wei Hou; Sujata Choudhury; Bhaskar Kallakury; Dean G Tang; Thomas Darling; Rajesh Thangapazham; Olga Timofeeva; Anatoly Dritschilo; Scott H Randell; Christopher Albanese; Seema Agarwal; Richard Schlegel
Journal:  Nat Protoc       Date:  2017-01-26       Impact factor: 13.491

Review 2.  Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAART.

Authors:  C W Peterson; P Younan; K R Jerome; H-P Kiem
Journal:  Gene Ther       Date:  2013-01-31       Impact factor: 5.250

3.  Δ133p53α, a natural p53 isoform, contributes to conditional reprogramming and long-term proliferation of primary epithelial cells.

Authors:  Abdul M Mondal; Hua Zhou; Izumi Horikawa; Frank A Suprynowicz; Guangzhao Li; Aleksandra Dakic; Bernard Rosenthal; Lin Ye; Curtis C Harris; Richard Schlegel; Xuefeng Liu
Journal:  Cell Death Dis       Date:  2018-07-03       Impact factor: 8.469

4.  One method to establish Epstein-Barr virus-associated NK/T cell lymphoma mouse models.

Authors:  Weili Xue; Weiming Li; Yufeng Shang; Yanjie Zhang; Xuan Lan; Guannan Wang; Zhaoming Li; Xudong Zhang; Yue Song; Baopeng Wu; Meng Dong; Xinhua Wang; Mingzhi Zhang
Journal:  J Cell Mol Med       Date:  2018-11-28       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.